期刊文献+

奥氮平、利培酮、氯丙嗪对精神分裂症患者体质量及血脂影响的对照研究 被引量:2

Control study that olanzipine, risperidone, cldorpromazine affect on the body weight and the blood lipid of schizophrenic patients.
下载PDF
导出
摘要 目的比较奥氮平、利培酮、氯丙嗪对精神分裂症患者体质量和血脂的影响。方法观测体质量、血脂正常的精神分裂症患者服用奥氮平、利培酮、氯丙嗪后4周、8周、12周时的体质量、血脂的变化。结果发现服用奥氮平的精神分裂症男女患者体质量、TG均明显升高(P〈0.05~0.01),奥氮平组女性患者Tch也明显增高(P〈0.05),但男性患者的Tch增高无统计意义;利培酮组的体质量、TG、Tch几无变化;氯丙嗪组仅体质量有明显增加(P〈0.05),但TG、Tch增幅不大,无统计意义。结论奥氮平较利培酮、氯丙嗪更易引起患者体质量增加,血脂增高,应引起临床上高度重视。 Objective To compare the effects of the olanzapine, risperidone, and chlorpromazine on the body weight and blood lipid of schizophrenic patients. Methods Observing the changes of their body weight and blood lipid after they take olanzapine, risperidone and chlor- promazine 4 weeks,8 weeks and 12 weeks,while schizophrenic patients body weight and blood lipid are normal before taking 3 diugs. Results within the group taking olanzapine the body weight and TG of the male and female schizophrenic patients are obviously higher than before( P 〈 0. 05 - 0. 01 ) ; but Tchbecomes higher only in the female patients( P 〈 0. 05 ), and besides it is meaningless to collect the rise of Tch in the male patients;among the group taking risperidone,the body weight,TG and Tch of all the patients are only changed little;In the patients group taking chlorpromazine, only the body weight rises clearly (P 〈 0. 05 ), while the increasing width of TG and Tch is not very large and it is also meaning- less to collect it. Conclusion Olanzapine is much easier to cause the rise of body weight and blood lipid of schizophrenic patients, so we must pay more attention to this issue in clinics.
出处 《中外医学研究》 2010年第19期4-6,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 奥氮平 利培酮 氯丙嗪 体质量 血脂 Olanzapine Risperidone Chlorpromazine Body weight Blood lipid
  • 相关文献

参考文献7

  • 1中华医学会精神科分会.中国精神障碍分类与诊断标准第3版[M].济南:山东科学技术出版社,2001.53.
  • 2Meyer JM.A retrospective comparison of weight,lipid,and glucose changes between risperodone and olanzapine treated inpients metabolic outcomes after 1 year.J Clin Psychiatry,2002,3(5):425-432.
  • 3Meldersson KI,HultingAL,Brismar KI.Elevated levels of insulin,leptin,and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.Clin Pychiatry,2000:742-749.
  • 4贺朝晖.利培酮和氯氮平对体重及血脂影响的对照分析[J].临床精神医学杂志,2000,10(5):273-274. 被引量:31
  • 5Meyer JM.Noel antipsychotics and severe hyperlipidemia.J Clin Psychopharmacol,369-374.
  • 6Neyer JM.Effects of switching from olanzaping to risperidone on the prevalence of the metabolic syndome in overweight or obese patients with schizophrenia or schizoaffective disorder:analysis of a multicenter,rater-blinded,open-labe study.J Clin psychiatry,2005,27:1930-1941.
  • 7Stroup TS.Effectiveness of olanzapine,quetine,risperidone,and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.Am J psychiatry,2006,163:611-622.

二级参考文献3

共引文献71

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部